Pharmafile Logo

toothbrush

- PMLiVE

PM Society announces launch of PMi Awards 2025

The event will take place on Thursday 11 September at the Brewery in London

- PMLiVE

Women in pharma

PME talks to Kay Wesley, CEO of Kanga Health, about her career in pharma

- PMLiVE

GSK’s antibiotic Blujepa granted FDA approval to treat urinary tract infections

Blujepa is the first in a new class of oral antibiotics for uncomplicated UTIs in nearly 30 years

- PMLiVE

J&J shares overall survival results for Rybrevant/Lazcluze combination in lung cancer

The regimen was approved by the MHRA earlier this month to treat EGFR-mutated NSCLC

- PMLiVE

FDA approves Soleno’s Vykat XR as first treatment for hyperphagia in Prader-Willi syndrome

The rare genetic disorder affects an estimated one in every 15,000 newborns in the US

- PMLiVE

Fox&Cat appoints Kim Walker as partner and managing director

Walker most recently served as managing director of GCI Health London

- PMLiVE

Innovation’s one real law

Playing with the NIH risks unintended consequences

- PMLiVE

The Cat’s Out of the Bag… Kim Walker, ex-GCI Health, Joins Fox&Cat as Partner and Managing Director

Fox&Cat appoints Kim Walker as Partner and Managing Director, bringing leadership strength and operational focus to the agency. Her arrival enhances Fox&Cat’s ADAPT™ methodology and consultancy model, reinforcing its commitment...

Fox&Cat

- PMLiVE

Merck gains rights to Hengrui’s heart disease candidate in deal worth almost $2bn

Cardiovascular diseases result in an estimated 17.9 million global deaths each year

- PMLiVE

Sanofi’s investigational MS treatment tolebrutinib granted FDA priority review

Approximately 2.9 million people worldwide are living with the neurodegenerative disease

- PMLiVE

UKHSA releases list of pathogens posing ‘greatest risk’ to public health

The agency has listed 24 pathogen families where preparedness efforts are most needed

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links